Vytorin
Merck and Schering Plough launched Vytorin (a combination of Schering’s Zetia and Merck’s Zocor) in 2004 to address the anti-cholesterol market. Lipitor had enjoyed considerable success since their launch, so the name incorporates the –tor- infix to identify the category and is structured to create the feeling of vibrancy, power and energy.
